Pulse Biosciences (PLSE) Net Cash Flow (2015 - 2025)
Pulse Biosciences (PLSE) posted quarterly Net Cash Flow of -$14.5 million for Q4 2025, down 137.12% year-over-year from $39.0 million in Q4 2024, and down 30.03% quarter-over-quarter from -$11.1 million in Q3 2025.
Pulse Biosciences (PLSE) Net Cash Flow (2015 - 2025) Analysis & Trends
Pulse Biosciences' Net Cash Flow history runs 11 years deep, the most recent figure standing at -$14.5 million for Q4 2025.
- In Q4 2025, Net Cash Flow fell 137.12% year-over-year to -$14.5 million; the TTM figure through Dec 2025 stood at -$37.3 million (down 150.63% YoY), while the FY2025 annual figure was -$37.3 million, down 150.63% from the prior year.
- Net Cash Flow for Q4 2025 stood at -$14.5 million, down from -$11.1 million in the prior quarter.
- The five-year high for Net Cash Flow was $54.4 million in Q3 2022, with the low at -$15.9 million in Q1 2022.
- The 5-year median for Net Cash Flow is -$7.5 million (2022), against an average of $3.4 million.
- Peak annual rise in Net Cash Flow reached 4813.99% in 2021, while the deepest fall reached 348.04% in 2021.
- Pulse Biosciences' Net Cash Flow stood at -$13.4 million in 2021, then jumped by 40.02% to -$8.0 million in 2022, then grew by 24.95% to -$6.0 million in 2023, then soared by 747.82% to $39.0 million in 2024, then slumped by 137.12% to -$14.5 million in 2025.
- Business Quant data shows PLSE's Net Cash Flow at -$14.5 million in Q4 2025, -$11.1 million in Q3 2025, and -$12.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 746.50 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -42.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -192.18 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 95.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -84.00 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -160.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 17.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 149.00 Mn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.48 Mn |
| Dec 31, 2025 | -14.48 Mn |
| Sep 30, 2025 | -11.14 Mn |
| Sep 30, 2025 | -11.14 Mn |
| Jun 30, 2025 | -12.93 Mn |
| Jun 30, 2025 | -12.93 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 39.01 Mn |
| Dec 31, 2024 | 39.01 Mn |
| Sep 30, 2024 | 52.84 Mn |
| Sep 30, 2024 | 52.84 Mn |
| Jun 30, 2024 | -8.69 Mn |
| Jun 30, 2024 | -8.69 Mn |
| Mar 31, 2024 | -9.48 Mn |
| Mar 31, 2024 | -9.48 Mn |
| Dec 31, 2023 | -6.02 Mn |
| Dec 31, 2023 | -6.02 Mn |
| Sep 30, 2023 | -8.36 Mn |
| Sep 30, 2023 | -8.36 Mn |